Emmanuelle Verger
- Genetics top 2%
- Hematology top 2%
- Molecular Biology
- Rheumatology top 5%
- Oncology
- Co-authors
- Bruno CassinatJean‐Jacques KiladjianNabih MaslahStéphane GiraudierChristine ChomienneJacques ÉlionMarie‐Hélène SchlageterLaura Evelia Torres Velázquez
- Topics
- Myeloproliferative Neoplasms: Diagnosis and Treatment (27 papers)Acute Myeloid Leukemia Research (12 papers)Chronic Myeloid Leukemia Treatments (12 papers)
- Cited by
- GeneticsHematologyRheumatology
- Partner nations
- FranceUnited StatesAustria
In The Last Decade
Emmanuelle Verger
31 papers receiving 658 citations
Peers
Comparison fields: 5 of 55
- Genetics 468
- Hematology 432
- Molecular Biology 299
- Rheumatology 202
- Oncology 80
Countries citing papers authored by Emmanuelle Verger
This map shows the geographic impact of Emmanuelle Verger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuelle Verger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuelle Verger more than expected).
Fields of papers citing papers by Emmanuelle Verger
This network shows the impact of papers produced by Emmanuelle Verger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuelle Verger. The network helps show where Emmanuelle Verger may publish in the future.
Co-authorship network of co-authors of Emmanuelle Verger
This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuelle Verger. A scholar is included among the top collaborators of Emmanuelle Verger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuelle Verger. Emmanuelle Verger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 7 | |
| 3 | 20 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 19 | |
| 7 | 30 | |
| 8 | 18 | |
| 9 | 2 | |
| 10 | 24 | |
| 11 | 2 | |
| 12 | 3 | |
| 13 | 100 | |
| 14 | 3 | |
| 15 | 16 | |
| 16 | 31 | |
| 17 | 77 | |
| 18 | 109 | |
| 19 | 20 | |
| 20 | 16 |
About Emmanuelle Verger
Emmanuelle Verger is a scholar working on Genetics, Hematology and Rheumatology, having authored 34 papers that have together received 663 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (27 papers), Acute Myeloid Leukemia Research (12 papers) and Chronic Myeloid Leukemia Treatments (12 papers). The work is most often cited by research in Genetics (468 citations), Hematology (432 citations) and Rheumatology (202 citations). Emmanuelle Verger has collaborated with scholars based in France, United States and Austria. Frequent co-authors include Bruno Cassinat, Jean‐Jacques Kiladjian, Nabih Maslah, Stéphane Giraudier, Christine Chomienne, Jacques Élion, Marie‐Hélène Schlageter, Laura Evelia Torres Velázquez, Ana Cristina Silva‐Pinto and Marie‐Hélène Odièvre. Their work appears in journals such as The Journal of Experimental Medicine, Blood and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.